Vaidya Sane Ayurved Laboratories Ltd Financials
Company Logo

Vaidya Sane Ayurved Laboratories Ltd Financial Statement

Vaidya Sane Ayurved Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Vaidya Sane Ayurved Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual87.11
Operating Expenses Annual76.98
Operating Profit Annual10.70
Interest Annual0.10
Depreciation2.25
Net Profit Annual4.90
Tax Annual1.97

Vaidya Sane Ayurved Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning2.19
Cash Flow from Operations7.58
Cash Flow from Investing-6.91
Cash Flow from Financing-0.54
Cash Flow at the End2.32

Vaidya Sane Ayurved Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)13.66
PBIT Margin (%)9.38
PBT Margin (%)-84.41
Net PROFIT Margin (%)5.63
Return On Networth / Equity (%)10.04
Return On Networth /Employed (%)13.28
Return On Assets (%)7.99
Total Debt / Equity (X)0.03
Asset Turnover Ratio (%)1.42

Vaidya Sane Ayurved Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual28.23
Total Current Assets Annual25.59
Non Current Assets Annual48.24
Total Shareholders Funds Annual59.70
Total Assets Annual73.83

Vaidya Sane Ayurved Laboratories Ltd Earning Calls

No Data Availabe

FAQS on Vaidya Sane Ayurved Laboratories Ltd Financials

As of Apr 14, 2026, Vaidya Sane Ayurved Laboratories Ltd has a market capitalization of 98.51 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Vaidya Sane Ayurved Laboratories Ltd is with a debt-to-equity ratio of 0.02.

In FY 2025 , Vaidya Sane Ayurved Laboratories Ltd recorded a total revenue of approximately 87.11 Cr marking a significant milestone in the company's financial performance.

Vaidya Sane Ayurved Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.5% and -0.1% annually, respectively..

Vaidya Sane Ayurved Laboratories Ltd's current PE ratio is 20.10.

Vaidya Sane Ayurved Laboratories Ltd's ROCE averaged 11.1% from the FY ending March 2023 to 2025, with a median of 13.1%. It peaked at 17.3% in March 2023, reflecting strong capital efficiency over the period..

Vaidya Sane Ayurved Laboratories Ltd's latest EBIT is Rs. 6.97 Cr, surpassing the average EBIT of Rs. 5.26 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions